KEGG   DRUG: Diphenhydramine
Entry
D00300                      Drug                                   
Name
Diphenhydramine (JP18/INN);
Restamin (TN)
Formula
C17H21NO
Exact mass
255.1623
Mol weight
255.3547
Structure
Simcomp
Class
Anti-allergic agent
 DG01557  Histamine receptor antagonist
  DG01482  Histamine receptor H1 antagonist
Remark
Same as: C06960
Therapeutic category: 2642
ATC code: D04AA32 R06AA02
Chemical structure group: DG00390
Product (DG00390): D00300<JP> D00669<JP/US> D03360<JP> D00520<JP/US>
Efficacy
Antiallergic, H1 receptor antagonist
Comment
Diphenhydramine derivative
Target
HRH1 [HSA:3269] [KO:K04149]
  Pathway
hsa04020  Calcium signaling pathway
hsa04080  Neuroactive ligand-receptor interaction
Interaction
Structure map
map07028  Antipsychotics
map07032  Hypnotics
map07212  Histamine H1 receptor antagonists
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 D DERMATOLOGICALS
  D04 ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.
   D04A ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.
    D04AA Antihistamines for topical use
     D04AA32 Diphenhydramine
      D00300  Diphenhydramine (JP18/INN) <JP>
 R RESPIRATORY SYSTEM
  R06 ANTIHISTAMINES FOR SYSTEMIC USE
   R06A ANTIHISTAMINES FOR SYSTEMIC USE
    R06AA Aminoalkyl ethers
     R06AA02 Diphenhydramine
      D00300  Diphenhydramine (JP18/INN) <JP>
Therapeutic category of drugs in Japan [BR:br08301]
 2  Agents affecting individual organs
  26  Epidermides
   264  Analgesics, anti-itchings, astringents, anti-inflammatory agents
    2642  Antihistamines for external use
     D00300  Diphenhydramine (JP18/INN)
Classification of Japanese OTC drugs [BR:br08313]
 Agents for integumentary system
  57 Analgesic, antipruritic, astringent, and anti-inflammatory remedies (incl. gel patches)
   D00300  Diphenhydramine (JP18/INN)
Risk category of Japanese OTC drugs [BR:br08312]
 Designated second-class OTC drugs
  Inorganic and organic chemicals
   Diphenhydramine
    D00300  Diphenhydramine (JP18/INN)
 Second-class OTC drugs
  Inorganic and organic chemicals
   Diphenhydramine
    D00300  Diphenhydramine (JP18/INN)
 Third-class OTC drugs
  Inorganic and organic chemicals
   Diphenhydramine
    D00300  Diphenhydramine (JP18/INN)
Drug groups [BR:br08330]
 Anti-allergic agent
  DG01557  Histamine receptor antagonist
   DG01482  Histamine receptor H1 antagonist
    DG00390  Diphenhydramine
     D00300  Diphenhydramine
Drug classes [BR:br08332]
 Anti-allergic agent
  DG01482  Histamine receptor H1 antagonist
   D00300  Diphenhydramine
Target-based classification of drugs [BR:br08310]
 G Protein-coupled receptors
  Rhodopsin family
   Histamine
    HRH1
     D00300  Diphenhydramine (JP18/INN) <JP>
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
 Chemicals
  D00300  Diphenhydramine
Drug groups [BR:br08330]
 Anti-allergic agent
  DG01557  Histamine receptor antagonist
   DG01482  Histamine receptor H1 antagonist
    DG00390  Diphenhydramine
Other DBs
CAS: 58-73-1
PubChem: 7847366
ChEBI: 4636
PDB-CCD: 2PM[PDBj]
LigandBox: D00300
NIKKAJI: J1.390K
LinkDB
KCF data

ATOM        19
            1   C1c C    30.1190  -16.7924
            2   C8y C    28.9084  -17.4966
            3   C8y C    31.3355  -17.4966
            4   O2a O    30.1249  -15.3955
            5   C8x C    28.9084  -18.8994
            6   C8x C    27.6977  -16.7924
            7   C8x C    31.3298  -18.8994
            8   C8x C    32.5403  -16.7924
            9   C1b C    31.3355  -14.6912
            10  C8x C    27.6977  -19.5919
            11  C8x C    26.4812  -17.4966
            12  C8x C    32.5403  -19.5919
            13  C8x C    33.7568  -17.4966
            14  C8x C    26.4812  -18.8994
            15  C8x C    33.7509  -18.8994
            16  C1b C    32.5712  -15.4021
            17  N1c N    33.7675  -14.7088
            18  C1a C    34.9566  -15.3928
            19  C1a C    33.7653  -13.3002
BOND        20
            1     5  10 2
            2     6  11 1
            3     7  12 1
            4     8  13 2
            5    10  14 1
            6    12  15 2
            7    11  14 2
            8    13  15 1
            9     1   2 1
            10    1   3 1
            11    1   4 1
            12    2   5 1
            13    2   6 2
            14    3   7 2
            15    3   8 1
            16    4   9 1
            17    9  16 1
            18   16  17 1
            19   17  18 1
            20   17  19 1

» Japanese version   » Back

KEGG   DRUG: Diphenhydramine hydrochloride
Entry
D00669                      Drug                                   
Name
Diphenhydramine hydrochloride (JP18/USP);
Benadryl (TN)
Product
  Generic
Formula
C17H21NO. HCl
Exact mass
291.139
Mol weight
291.8157
Structure
Simcomp
Class
Anti-allergic agent
 DG01557  Histamine receptor antagonist
  DG01482  Histamine receptor H1 antagonist
Remark
Same as: C07784
Therapeutic category: 4411
ATC code: D04AA32 R06AA02
Chemical structure group: DG00390
Product (DG00390): D00300<JP> D00669<JP/US> D03360<JP> D00520<JP/US>
Product (mixture): D04259<JP> D04806<JP> D08769<JP>
Efficacy
Antiallergic, H1 receptor antagonist
  Disease
Parkinsonism [DS:H01600]
Nighttime sleep-aid [DS:H01609]
Comment
Diphenhydramine derivative
Target
HRH1 [HSA:3269] [KO:K04149]
  Pathway
hsa04020  Calcium signaling pathway
hsa04080  Neuroactive ligand-receptor interaction
Interaction
Structure map
map07028  Antipsychotics
map07032  Hypnotics
map07212  Histamine H1 receptor antagonists
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 D DERMATOLOGICALS
  D04 ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.
   D04A ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.
    D04AA Antihistamines for topical use
     D04AA32 Diphenhydramine
      D00669  Diphenhydramine hydrochloride (JP18/USP) <JP/US>
 R RESPIRATORY SYSTEM
  R06 ANTIHISTAMINES FOR SYSTEMIC USE
   R06A ANTIHISTAMINES FOR SYSTEMIC USE
    R06AA Aminoalkyl ethers
     R06AA02 Diphenhydramine
      D00669  Diphenhydramine hydrochloride (JP18/USP) <JP/US>
USP drug classification [BR:br08302]
 Antiemetics
  Antiemetics, Other
   Diphenhydramine
    D00669  Diphenhydramine hydrochloride (JP18/USP)
 Antiparkinson Agents
  Anticholinergics
   Diphenhydramine
    D00669  Diphenhydramine hydrochloride (JP18/USP)
 Respiratory Tract/Pulmonary Agents
  Antihistamines
   Histamine (H1) Receptor Antagonists, Sedating
    Diphenhydramine
     D00669  Diphenhydramine hydrochloride (JP18/USP)
Therapeutic category of drugs in Japan [BR:br08301]
 4  Agents affecting cellular function
  44  Allergic agents
   441  Antihistamines
    4411  Diphenhydramines
     D00669  Diphenhydramine hydrochloride (JP18/USP)
Classification of Japanese OTC drugs [BR:br08313]
 Agents for nervous and sensory systems
  01 Cold remedy (oral use)
   D00669  Diphenhydramine hydrochloride (JP18/USP)
  04 Sedative hypnotic agents
   D00669  Diphenhydramine hydrochloride (JP18/USP)
  06 Antivertigo drugs (incl. motion/morning sickness remedies)
   D00669  Diphenhydramine hydrochloride (JP18/USP)
 Allergic agents
  52 Antihistamine based drugs
   D00669  Diphenhydramine hydrochloride (JP18/USP)
 Agents for integumentary system
  57 Analgesic, antipruritic, astringent, and anti-inflammatory remedies (incl. gel patches)
   D00669  Diphenhydramine hydrochloride (JP18/USP)
 Agents for ophthalmologic use
  64 Allergy eye drops
   D00669  Diphenhydramine hydrochloride (JP18/USP)
Risk category of Japanese OTC drugs [BR:br08312]
 Designated second-class OTC drugs
  Inorganic and organic chemicals
   Diphenhydramine
    D00669  Diphenhydramine hydrochloride (JP18/USP)
 Second-class OTC drugs
  Inorganic and organic chemicals
   Diphenhydramine
    D00669  Diphenhydramine hydrochloride (JP18/USP)
 Third-class OTC drugs
  Inorganic and organic chemicals
   Diphenhydramine
    D00669  Diphenhydramine hydrochloride (JP18/USP)
Drug groups [BR:br08330]
 Anti-allergic agent
  DG01557  Histamine receptor antagonist
   DG01482  Histamine receptor H1 antagonist
    DG00390  Diphenhydramine
     D00669  Diphenhydramine hydrochloride
Drug classes [BR:br08332]
 Anti-allergic agent
  DG01482  Histamine receptor H1 antagonist
   D00669  Diphenhydramine hydrochloride
Target-based classification of drugs [BR:br08310]
 G Protein-coupled receptors
  Rhodopsin family
   Histamine
    HRH1
     D00669  Diphenhydramine hydrochloride (JP18/USP) <JP/US>
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
 Chemicals
  D00669  Diphenhydramine hydrochloride
Rx-to-OTC switch list in the USA [br08315.html]
 D00669
Drug groups [BR:br08330]
 Anti-allergic agent
  DG01557  Histamine receptor antagonist
   DG01482  Histamine receptor H1 antagonist
    DG00390  Diphenhydramine
Other DBs
CAS: 147-24-0
PubChem: 7847735
ChEBI: 4637
LigandBox: D00669
NIKKAJI: J237.227D
LinkDB
KCF data

ATOM        20
            1   X   Cl   34.6500  -16.2400
            2   C1c C    28.0247  -15.1856
            3   C8y C    26.8139  -15.8899
            4   C8y C    29.2415  -15.8899
            5   O2a O    28.0306  -13.7884
            6   C8x C    26.8139  -17.2930
            7   C8x C    25.6030  -15.1856
            8   C8x C    29.2358  -17.2930
            9   C8x C    30.4465  -15.1856
            10  C1b C    29.2415  -13.0840
            11  C8x C    25.6030  -17.9856
            12  C8x C    24.3862  -15.8899
            13  C8x C    30.4465  -17.9856
            14  C8x C    31.6632  -15.8899
            15  C8x C    24.3862  -17.2930
            16  C8x C    31.6573  -17.2930
            17  C1b C    30.4774  -13.7950
            18  N1c N    31.6739  -13.1016
            19  C1a C    32.8632  -13.7857
            20  C1a C    31.6717  -11.6927
BOND        20
            1     6  11 2
            2     7  12 1
            3     8  13 1
            4     9  14 2
            5    11  15 1
            6    13  16 2
            7    12  15 2
            8    14  16 1
            9     2   3 1
            10    2   4 1
            11    2   5 1
            12    3   6 1
            13    3   7 2
            14    4   8 2
            15    4   9 1
            16    5  10 1
            17   10  17 1
            18   17  18 1
            19   18  19 1
            20   18  20 1

» Japanese version   » Back

KEGG   DRUG: Diphenhydramine salicylate
Entry
D02419                      Drug                                   
Name
Diphenhydramine salicylate (JAN)
Formula
C17H21NO. C7H6O3
Exact mass
393.194
Mol weight
393.4755
Structure
Simcomp
Class
Anti-allergic agent
 DG01557  Histamine receptor antagonist
  DG01482  Histamine receptor H1 antagonist
Remark
Same as: C14015
ATC code: D04AA32 R06AA02
Chemical structure group: DG00390
Product (DG00390): D00300<JP> D00669<JP/US> D03360<JP> D00520<JP/US>
Product (mixture): D04261<JP> D04425<JP> D08695<JP>
Efficacy
Antiallergic, Antivertigo, H1 receptor antagonist
Target
HRH1 [HSA:3269] [KO:K04149]
  Pathway
hsa04020  Calcium signaling pathway
hsa04080  Neuroactive ligand-receptor interaction
Interaction
Structure map
map07028  Antipsychotics
map07032  Hypnotics
map07212  Histamine H1 receptor antagonists
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 D DERMATOLOGICALS
  D04 ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.
   D04A ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.
    D04AA Antihistamines for topical use
     D04AA32 Diphenhydramine
      D02419  Diphenhydramine salicylate (JAN)
 R RESPIRATORY SYSTEM
  R06 ANTIHISTAMINES FOR SYSTEMIC USE
   R06A ANTIHISTAMINES FOR SYSTEMIC USE
    R06AA Aminoalkyl ethers
     R06AA02 Diphenhydramine
      D02419  Diphenhydramine salicylate (JAN)
Classification of Japanese OTC drugs [BR:br08313]
 Agents for nervous and sensory systems
  06 Antivertigo drugs (incl. motion/morning sickness remedies)
   D02419  Diphenhydramine salicylate (JAN)
 Allergic agents
  52 Antihistamine based drugs
   D02419  Diphenhydramine salicylate (JAN)
Risk category of Japanese OTC drugs [BR:br08312]
 Second-class OTC drugs
  Inorganic and organic chemicals
   Diphenhydramine
    D02419  Diphenhydramine salicylate (JAN)
 Third-class OTC drugs
  Inorganic and organic chemicals
   Diphenhydramine
    D02419  Diphenhydramine salicylate (JAN)
Drug groups [BR:br08330]
 Anti-allergic agent
  DG01557  Histamine receptor antagonist
   DG01482  Histamine receptor H1 antagonist
    DG00390  Diphenhydramine
     D02419  Diphenhydramine salicylate
Target-based classification of drugs [BR:br08310]
 G Protein-coupled receptors
  Rhodopsin family
   Histamine
    HRH1
     D02419  Diphenhydramine salicylate (JAN)
Drug groups [BR:br08330]
 Anti-allergic agent
  DG01557  Histamine receptor antagonist
   DG01482  Histamine receptor H1 antagonist
    DG00390  Diphenhydramine
Other DBs
CAS: 7491-10-3
PubChem: 7849477
ChEBI: 34720 4636
LigandBox: D02419
NIKKAJI: J280.985K
LinkDB
KCF data

ATOM        29
            1   C8y C    35.4176  -17.2194
            2   C8y C    36.6305  -17.9191
            3   C8x C    34.2047  -17.9191
            4   C6a C    35.4176  -15.8198
            5   C8x C    36.6305  -19.3186
            6   O1a O    37.8433  -17.2194
            7   C8x C    34.2047  -19.3186
            8   O6a O    36.6305  -15.1201
            9   O6a O    34.2047  -15.1201
            10  C8x C    35.4176  -20.0183
            11  C1c C    26.8347  -17.2856
            12  C8y C    25.6239  -17.9899
            13  C8y C    28.0515  -17.9899
            14  O2a O    26.8406  -15.8884
            15  C8x C    25.6239  -19.3930
            16  C8x C    24.4130  -17.2856
            17  C8x C    28.0458  -19.3930
            18  C8x C    29.2565  -17.2856
            19  C1b C    28.0515  -15.1840
            20  C8x C    24.4130  -20.0856
            21  C8x C    23.1962  -17.9899
            22  C8x C    29.2565  -20.0856
            23  C8x C    30.4732  -17.9899
            24  C8x C    23.1962  -19.3930
            25  C8x C    30.4673  -19.3930
            26  C1b C    29.2874  -15.8950
            27  N1c N    30.4839  -15.2016
            28  C1a C    31.6732  -15.8857
            29  C1a C    30.4817  -13.7927
BOND        30
            1     1   2 1
            2     1   3 2
            3     1   4 1
            4     2   5 2
            5     2   6 1
            6     3   7 1
            7     4   8 1
            8     4   9 2
            9     5  10 1
            10    7  10 2
            11   15  20 2
            12   16  21 1
            13   17  22 1
            14   18  23 2
            15   20  24 1
            16   22  25 2
            17   21  24 2
            18   23  25 1
            19   11  12 1
            20   11  13 1
            21   11  14 1
            22   12  15 1
            23   12  16 2
            24   13  17 2
            25   13  18 1
            26   14  19 1
            27   19  26 1
            28   26  27 1
            29   27  28 1
            30   27  29 1

» Japanese version   » Back

KEGG   DRUG: Diphenhydramine tannate
Entry
D03285                      Drug                                   
Name
Diphenhydramine tannate (JP18);
Restamin A (TN)
Class
Anti-allergic agent
 DG01557  Histamine receptor antagonist
  DG01482  Histamine receptor H1 antagonist
Remark
ATC code: D04AA32 R06AA02
Chemical structure group: DG00390
Product (DG00390): D00300<JP> D00669<JP/US> D03360<JP> D00520<JP/US>
Efficacy
Antiallergic, H1 receptor antagonist
Comment
Diphenhydramine derivative
Target
HRH1 [HSA:3269] [KO:K04149]
  Pathway
hsa04020  Calcium signaling pathway
hsa04080  Neuroactive ligand-receptor interaction
Interaction
Structure map
map07032  Hypnotics
map07212  Histamine H1 receptor antagonists
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 D DERMATOLOGICALS
  D04 ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.
   D04A ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.
    D04AA Antihistamines for topical use
     D04AA32 Diphenhydramine
      D03285  Diphenhydramine tannate (JP18)
 R RESPIRATORY SYSTEM
  R06 ANTIHISTAMINES FOR SYSTEMIC USE
   R06A ANTIHISTAMINES FOR SYSTEMIC USE
    R06AA Aminoalkyl ethers
     R06AA02 Diphenhydramine
      D03285  Diphenhydramine tannate (JP18)
Risk category of Japanese OTC drugs [BR:br08312]
 Second-class OTC drugs
  Inorganic and organic chemicals
   Diphenhydramine
    D03285  Diphenhydramine tannate (JP18)
Drug groups [BR:br08330]
 Anti-allergic agent
  DG01557  Histamine receptor antagonist
   DG01482  Histamine receptor H1 antagonist
    DG00390  Diphenhydramine
     D03285  Diphenhydramine tannate
Target-based classification of drugs [BR:br08310]
 G Protein-coupled receptors
  Rhodopsin family
   Histamine
    HRH1
     D03285  Diphenhydramine tannate (JP18)
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
 Chemicals
  D03285  Diphenhydramine tannate
Drug groups [BR:br08330]
 Anti-allergic agent
  DG01557  Histamine receptor antagonist
   DG01482  Histamine receptor H1 antagonist
    DG00390  Diphenhydramine
Other DBs
PubChem: 17397437
LinkDB

» Japanese version   » Back

KEGG   DRUG: Diphenhydramine laurylsulfate
Entry
D03360                      Drug                                   
Name
Diphenhydramine laurylsulfate (JAN);
Vena (TN)
Formula
C12H26O4S. C17H21NO
Exact mass
521.3175
Mol weight
521.7522
Structure
Class
Anti-allergic agent
 DG01557  Histamine receptor antagonist
  DG01482  Histamine receptor H1 antagonist
Remark
Therapeutic category: 2642
ATC code: D04AA32 R06AA02
Chemical structure group: DG00390
Product (DG00390): D00300<JP> D00669<JP/US> D03360<JP> D00520<JP/US>
Efficacy
Antiallergic, H1 receptor antagonist
Comment
Diphenhydramine derivative
Target
HRH1 [HSA:3269] [KO:K04149]
  Pathway
hsa04020  Calcium signaling pathway
hsa04080  Neuroactive ligand-receptor interaction
Interaction
Structure map
map07028  Antipsychotics
map07032  Hypnotics
map07212  Histamine H1 receptor antagonists
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 D DERMATOLOGICALS
  D04 ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.
   D04A ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.
    D04AA Antihistamines for topical use
     D04AA32 Diphenhydramine
      D03360  Diphenhydramine laurylsulfate (JAN) <JP>
 R RESPIRATORY SYSTEM
  R06 ANTIHISTAMINES FOR SYSTEMIC USE
   R06A ANTIHISTAMINES FOR SYSTEMIC USE
    R06AA Aminoalkyl ethers
     R06AA02 Diphenhydramine
      D03360  Diphenhydramine laurylsulfate (JAN) <JP>
Therapeutic category of drugs in Japan [BR:br08301]
 2  Agents affecting individual organs
  26  Epidermides
   264  Analgesics, anti-itchings, astringents, anti-inflammatory agents
    2642  Antihistamines for external use
     D03360  Diphenhydramine laurylsulfate (JAN)
Classification of Japanese OTC drugs [BR:br08313]
 Agents for integumentary system
  57 Analgesic, antipruritic, astringent, and anti-inflammatory remedies (incl. gel patches)
   D03360  Diphenhydramine laurylsulfate (JAN)
Risk category of Japanese OTC drugs [BR:br08312]
 Third-class OTC drugs
  Inorganic and organic chemicals
   Diphenhydramine
    D03360  Diphenhydramine laurylsulfate (JAN)
Drug groups [BR:br08330]
 Anti-allergic agent
  DG01557  Histamine receptor antagonist
   DG01482  Histamine receptor H1 antagonist
    DG00390  Diphenhydramine
     D03360  Diphenhydramine laurylsulfate
Drug classes [BR:br08332]
 Anti-allergic agent
  DG01482  Histamine receptor H1 antagonist
   D03360  Diphenhydramine laurylsulfate
Target-based classification of drugs [BR:br08310]
 G Protein-coupled receptors
  Rhodopsin family
   Histamine
    HRH1
     D03360  Diphenhydramine laurylsulfate (JAN) <JP>
Drug groups [BR:br08330]
 Anti-allergic agent
  DG01557  Histamine receptor antagonist
   DG01482  Histamine receptor H1 antagonist
    DG00390  Diphenhydramine
Other DBs
PubChem: 17397509
LigandBox: D03360
LinkDB
KCF data

ATOM        36
            1   C1c C    20.7534  -18.7629
            2   C8y C    19.5421  -19.4675
            3   C8y C    21.9707  -19.4675
            4   O2a O    20.7593  -17.3651
            5   C8x C    19.5421  -20.8712
            6   C8x C    18.3306  -18.7629
            7   C8x C    21.9650  -20.8712
            8   C8x C    23.1762  -18.7629
            9   C1b C    21.9707  -16.6604
            10  C8x C    18.3306  -21.5641
            11  C8x C    17.1133  -19.4675
            12  C8x C    23.1762  -21.5641
            13  C8x C    24.3935  -19.4675
            14  C8x C    17.1133  -20.8712
            15  C8x C    24.3876  -20.8712
            16  C1b C    23.2072  -17.3717
            17  N1c N    24.4042  -16.6780
            18  C1a C    25.5940  -17.3624
            19  C1a C    24.4020  -15.2685
            20  C1b C    43.4700  -19.3900
            21  C1b C    42.2800  -20.0900
            22  C1b C    41.0900  -19.3900
            23  C1b C    39.8300  -20.0900
            24  C1b C    38.6400  -19.3900
            25  C1b C    37.4500  -20.0900
            26  C1b C    36.2600  -19.3900
            27  C1b C    35.0700  -20.0900
            28  C1b C    33.8100  -19.3900
            29  C1b C    32.6200  -20.0900
            30  C1b C    31.4300  -19.3900
            31  O2a O    30.2400  -20.0900
            32  C1a C    44.7300  -20.0900
            33  S4a S    28.8400  -20.0900
            34  O1d O    27.4400  -20.0900
            35  O1d O    28.8400  -18.6900
            36  O1d O    28.8400  -21.4900
BOND        36
            1     5  10 2
            2     6  11 1
            3     7  12 1
            4     8  13 2
            5    10  14 1
            6    12  15 2
            7    11  14 2
            8    13  15 1
            9     1   2 1
            10    1   3 1
            11    1   4 1
            12    2   5 1
            13    2   6 2
            14    3   7 2
            15    3   8 1
            16    4   9 1
            17    9  16 1
            18   16  17 1
            19   17  18 1
            20   17  19 1
            21   20  21 1
            22   21  22 1
            23   22  23 1
            24   23  24 1
            25   24  25 1
            26   25  26 1
            27   26  27 1
            28   27  28 1
            29   28  29 1
            30   29  30 1
            31   30  31 1
            32   20  32 1
            33   31  33 1
            34   33  34 1
            35   33  35 2
            36   33  36 2

» Japanese version   » Back

KEGG   DRUG: Diphenhydramine citrate
Entry
D03854                      Drug                                   
Name
Diphenhydramine citrate (USP)
Formula
C17H21NO. C6H8O7
Exact mass
447.1893
Mol weight
447.4783
Structure
Simcomp
Class
Anti-allergic agent
 DG01557  Histamine receptor antagonist
  DG01482  Histamine receptor H1 antagonist
Remark
ATC code: D04AA32 R06AA02
Chemical structure group: DG00390
Product (DG00390): D00300<JP> D00669<JP/US> D03360<JP> D00520<JP/US>
Efficacy
Antiallergic, H1 receptor antagonist
Comment
Component of Advil PM (TN)
Target
HRH1 [HSA:3269] [KO:K04149]
  Pathway
hsa04020  Calcium signaling pathway
hsa04080  Neuroactive ligand-receptor interaction
Interaction
Structure map
map07028  Antipsychotics
map07032  Hypnotics
map07212  Histamine H1 receptor antagonists
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 D DERMATOLOGICALS
  D04 ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.
   D04A ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.
    D04AA Antihistamines for topical use
     D04AA32 Diphenhydramine
      D03854  Diphenhydramine citrate (USP)
 R RESPIRATORY SYSTEM
  R06 ANTIHISTAMINES FOR SYSTEMIC USE
   R06A ANTIHISTAMINES FOR SYSTEMIC USE
    R06AA Aminoalkyl ethers
     R06AA02 Diphenhydramine
      D03854  Diphenhydramine citrate (USP)
Drug groups [BR:br08330]
 Anti-allergic agent
  DG01557  Histamine receptor antagonist
   DG01482  Histamine receptor H1 antagonist
    DG00390  Diphenhydramine
     D03854  Diphenhydramine citrate
Target-based classification of drugs [BR:br08310]
 G Protein-coupled receptors
  Rhodopsin family
   Histamine
    HRH1
     D03854  Diphenhydramine citrate (USP)
Rx-to-OTC switch list in the USA [br08315.html]
 D03854
Drug groups [BR:br08330]
 Anti-allergic agent
  DG01557  Histamine receptor antagonist
   DG01482  Histamine receptor H1 antagonist
    DG00390  Diphenhydramine
Other DBs
CAS: 88637-37-0
PubChem: 17397939
LigandBox: D03854
NIKKAJI: J349.769K
LinkDB
KCF data

ATOM        32
            1   C1d C    36.2422  -15.4018
            2   C1b C    35.0410  -16.0923
            3   C1b C    37.4434  -16.0864
            4   C6a C    36.9267  -14.1946
            5   O1a O    35.5399  -14.1946
            6   C6a C    33.8455  -15.4075
            7   C6a C    37.4317  -17.4735
            8   O6a O    36.2248  -12.9878
            9   O6a O    38.3196  -14.1946
            10  O6a O    32.6444  -16.1040
            11  O6a O    33.9027  -14.0206
            12  O6a O    38.6332  -18.1697
            13  O6a O    36.2248  -18.1638
            14  C1c C    24.5247  -16.5156
            15  C8y C    23.3139  -17.2199
            16  C8y C    25.7415  -17.2199
            17  O2a O    24.5306  -15.1184
            18  C8x C    23.3139  -18.6230
            19  C8x C    22.1030  -16.5156
            20  C8x C    25.7358  -18.6230
            21  C8x C    26.9465  -16.5156
            22  C1b C    25.7415  -14.4140
            23  C8x C    22.1030  -19.3156
            24  C8x C    20.8862  -17.2199
            25  C8x C    26.9465  -19.3156
            26  C8x C    28.1632  -17.2199
            27  C8x C    20.8862  -18.6230
            28  C8x C    28.1573  -18.6230
            29  C1b C    26.9774  -15.1250
            30  N1c N    28.1739  -14.4316
            31  C1a C    29.3632  -15.1157
            32  C1a C    28.1717  -13.0227
BOND        32
            1     1   2 1
            2     1   3 1
            3     1   4 1
            4     1   5 1
            5     2   6 1
            6     3   7 1
            7     4   8 1
            8     4   9 2
            9     6  10 1
            10    6  11 2
            11    7  12 1
            12    7  13 2
            13   18  23 2
            14   19  24 1
            15   20  25 1
            16   21  26 2
            17   23  27 1
            18   25  28 2
            19   24  27 2
            20   26  28 1
            21   14  15 1
            22   14  16 1
            23   14  17 1
            24   15  18 1
            25   15  19 2
            26   16  20 2
            27   16  21 1
            28   17  22 1
            29   22  29 1
            30   29  30 1
            31   30  31 1
            32   30  32 1

» Japanese version   » Back

DBGET integrated database retrieval system